---
schema_version: "secwatch.filing_event.v1"
accession: "0000716643-22-000023"
form_type: "8-K"
ticker: "RGS"
cik: "0000716643"
company_name: "REGIS CORP"
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-26T00:06:33.710047+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Regis appoints Matthew Doctor as permanent President and CEO, effective May 5, 2022

## Summary
- Matthew Doctor, 35, appointed President & CEO and director; had been interim CEO since Dec 2021.
- Base salary $600K/yr, target bonus 125% of base, max payout 225%; granted options for 875,000 shares.
- Options vest 20% on 1st anniversary, 20% on 2nd, 60% on 3rd; exercise price = closing price on grant date.
- Doctor previously EVP & Chief Strategy Officer at Regis, earlier at Restaurant Brands International and J.P. Morgan.
- Board chair David Grissen: 'Matt has stabilized the team, built trust with franchisees, laid groundwork for future.'

## SEC filing metadata
- accession: 0000716643-22-000023
- form_type: 8-K
- ticker: RGS
- cik: 0000716643
- company_name: REGIS CORP
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/rgs-20220504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000716643-22-000023
- JSON: https://secwatch.observer/filing/0000716643-22-000023.json
- Plain text: https://secwatch.observer/filing/0000716643-22-000023.txt

## Key facts
- Executive change
  Matthew Doctor was appointed as Director at REGIS CORP.
  - Action: appointed
  - Role: Director
  source text: On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").
  evidence_url: https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm
- Executive change
  Matthew Doctor was appointed as President and Chief Executive Officer at REGIS CORP.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On May 5, 2022, Regis Corporation (the "Company") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the "Board") effective May 5, 2022 ("Start Date").
  evidence_url: https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.